Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Emerging Therapies for Follicular Lymphoma

January 23rd 2018

FL: Updated Data for Immunomodulatory Approaches

January 23rd 2018

Immunomodulatory Therapy for FL: The R-Squared Regimen

January 23rd 2018

Further Considerations for Relapsed/Refractory FL

January 23rd 2018

Treatment Approaches to Relapsed Refractory FL

January 23rd 2018

Optimizing Frontline Therapy and Maintenance in FL

January 23rd 2018

Frontline Treatment Approaches to Follicular Lymphoma

January 23rd 2018

FL: Monitoring to Initiate Therapy and Gauge Response

January 23rd 2018

Risk Stratification and Outcomes in Follicular Lymphoma

January 23rd 2018

Diagnosis and Staging for Follicular Lymphoma

January 23rd 2018

Looking to the Future of Myeloma Care

January 23rd 2018

Improving Outcomes in Myeloma

January 23rd 2018

Immunotherapies in Myeloma

January 23rd 2018

Other Agents for Treating Myeloma

January 23rd 2018

Impact of MRD Assessment on Myeloma Treatment

January 23rd 2018

The Role of MRD Testing in Myeloma

January 23rd 2018

Adding Carfilzomib to R/R Myeloma Regimens

January 23rd 2018

Impact of Elotuzumab in R/R Myeloma Therapies

January 23rd 2018

Daratumumab-Based Regimens in R/R Myeloma

January 23rd 2018

The Role of Transplant in Myeloma

January 23rd 2018